Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.
Highlights
The global Single Cell Multiomics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Single Cell Multiomics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Single Cell Multiomics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Single Cell Multiomics in Oncology is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Single Cell Multiomics include 10x Genomics, Becton, Dickinson and Company, Berkeley Lights, BGI Genomics, Bio Rad Laboratories, Danaher Corporation (Cytiva Life Sciences), Dolomite Bio, Epicypher and Fluidigm Corporation, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Single Cell Multiomics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Cell Multiomics.
The Single Cell Multiomics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Single Cell Multiomics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single Cell Multiomics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
10x Genomics
Becton, Dickinson and Company
Berkeley Lights
BGI Genomics
Bio Rad Laboratories
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Epicypher
Fluidigm Corporation
Illimina
Miltenyi Biotec B.V. & CO.
Mission Bio
Nanostring Technologies
Olink Holding AB (Olink Proteomics)
Parse Bioscience
Qiagen N.V.
Takara Holdings Inc. Takara Bio Group
Thermo Fisher Scientific
Segment by Type
by Type
Single cell genomics
Single cell proteomics
Single cell transcriptomics
Single cell metabolomics
by Technique
Single cell isolation and dispensing
Single cell analysis
Segment by Application
Oncology
Cell biology
Neurology
Immunology
Stem cell research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single Cell Multiomics companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single Cell Multiomics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Single cell genomics
1.2.3 Single cell proteomics
1.2.4 Single cell transcriptomics
1.2.5 Single cell metabolomics
1.3 Market by Application
1.3.1 Global Single Cell Multiomics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Cell biology
1.3.4 Neurology
1.3.5 Immunology
1.3.6 Stem cell research
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single Cell Multiomics Market Perspective (2018-2029)
2.2 Single Cell Multiomics Growth Trends by Region
2.2.1 Global Single Cell Multiomics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Single Cell Multiomics Historic Market Size by Region (2018-2023)
2.2.3 Single Cell Multiomics Forecasted Market Size by Region (2024-2029)
2.3 Single Cell Multiomics Market Dynamics
2.3.1 Single Cell Multiomics Industry Trends
2.3.2 Single Cell Multiomics Market Drivers
2.3.3 Single Cell Multiomics Market Challenges
2.3.4 Single Cell Multiomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single Cell Multiomics Players by Revenue
3.1.1 Global Top Single Cell Multiomics Players by Revenue (2018-2023)
3.1.2 Global Single Cell Multiomics Revenue Market Share by Players (2018-2023)
3.2 Global Single Cell Multiomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Single Cell Multiomics Revenue
3.4 Global Single Cell Multiomics Market Concentration Ratio
3.4.1 Global Single Cell Multiomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single Cell Multiomics Revenue in 2022
3.5 Single Cell Multiomics Key Players Head office and Area Served
3.6 Key Players Single Cell Multiomics Product Solution and Service
3.7 Date of Enter into Single Cell Multiomics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Single Cell Multiomics Breakdown Data by Type
4.1 Global Single Cell Multiomics Historic Market Size by Type (2018-2023)
4.2 Global Single Cell Multiomics Forecasted Market Size by Type (2024-2029)
5 Single Cell Multiomics Breakdown Data by Application
5.1 Global Single Cell Multiomics Historic Market Size by Application (2018-2023)
5.2 Global Single Cell Multiomics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Single Cell Multiomics Market Size (2018-2029)
6.2 North America Single Cell Multiomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Single Cell Multiomics Market Size by Country (2018-2023)
6.4 North America Single Cell Multiomics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single Cell Multiomics Market Size (2018-2029)
7.2 Europe Single Cell Multiomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Single Cell Multiomics Market Size by Country (2018-2023)
7.4 Europe Single Cell Multiomics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single Cell Multiomics Market Size (2018-2029)
8.2 Asia-Pacific Single Cell Multiomics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Single Cell Multiomics Market Size by Region (2018-2023)
8.4 Asia-Pacific Single Cell Multiomics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Single Cell Multiomics Market Size (2018-2029)
9.2 Latin America Single Cell Multiomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Single Cell Multiomics Market Size by Country (2018-2023)
9.4 Latin America Single Cell Multiomics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single Cell Multiomics Market Size (2018-2029)
10.2 Middle East & Africa Single Cell Multiomics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Single Cell Multiomics Market Size by Country (2018-2023)
10.4 Middle East & Africa Single Cell Multiomics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 10x Genomics
11.1.1 10x Genomics Company Detail
11.1.2 10x Genomics Business Overview
11.1.3 10x Genomics Single Cell Multiomics Introduction
11.1.4 10x Genomics Revenue in Single Cell Multiomics Business (2018-2023)
11.1.5 10x Genomics Recent Development
11.2 Becton, Dickinson and Company
11.2.1 Becton, Dickinson and Company Company Detail
11.2.2 Becton, Dickinson and Company Business Overview
11.2.3 Becton, Dickinson and Company Single Cell Multiomics Introduction
11.2.4 Becton, Dickinson and Company Revenue in Single Cell Multiomics Business (2018-2023)
11.2.5 Becton, Dickinson and Company Recent Development
11.3 Berkeley Lights
11.3.1 Berkeley Lights Company Detail
11.3.2 Berkeley Lights Business Overview
11.3.3 Berkeley Lights Single Cell Multiomics Introduction
11.3.4 Berkeley Lights Revenue in Single Cell Multiomics Business (2018-2023)
11.3.5 Berkeley Lights Recent Development
11.4 BGI Genomics
11.4.1 BGI Genomics Company Detail
11.4.2 BGI Genomics Business Overview
11.4.3 BGI Genomics Single Cell Multiomics Introduction
11.4.4 BGI Genomics Revenue in Single Cell Multiomics Business (2018-2023)
11.4.5 BGI Genomics Recent Development
11.5 Bio Rad Laboratories
11.5.1 Bio Rad Laboratories Company Detail
11.5.2 Bio Rad Laboratories Business Overview
11.5.3 Bio Rad Laboratories Single Cell Multiomics Introduction
11.5.4 Bio Rad Laboratories Revenue in Single Cell Multiomics Business (2018-2023)
11.5.5 Bio Rad Laboratories Recent Development
11.6 Danaher Corporation (Cytiva Life Sciences)
11.6.1 Danaher Corporation (Cytiva Life Sciences) Company Detail
11.6.2 Danaher Corporation (Cytiva Life Sciences) Business Overview
11.6.3 Danaher Corporation (Cytiva Life Sciences) Single Cell Multiomics Introduction
11.6.4 Danaher Corporation (Cytiva Life Sciences) Revenue in Single Cell Multiomics Business (2018-2023)
11.6.5 Danaher Corporation (Cytiva Life Sciences) Recent Development
11.7 Dolomite Bio
11.7.1 Dolomite Bio Company Detail
11.7.2 Dolomite Bio Business Overview
11.7.3 Dolomite Bio Single Cell Multiomics Introduction
11.7.4 Dolomite Bio Revenue in Single Cell Multiomics Business (2018-2023)
11.7.5 Dolomite Bio Recent Development
11.8 Epicypher
11.8.1 Epicypher Company Detail
11.8.2 Epicypher Business Overview
11.8.3 Epicypher Single Cell Multiomics Introduction
11.8.4 Epicypher Revenue in Single Cell Multiomics Business (2018-2023)
11.8.5 Epicypher Recent Development
11.9 Fluidigm Corporation
11.9.1 Fluidigm Corporation Company Detail
11.9.2 Fluidigm Corporation Business Overview
11.9.3 Fluidigm Corporation Single Cell Multiomics Introduction
11.9.4 Fluidigm Corporation Revenue in Single Cell Multiomics Business (2018-2023)
11.9.5 Fluidigm Corporation Recent Development
11.10 Illimina
11.10.1 Illimina Company Detail
11.10.2 Illimina Business Overview
11.10.3 Illimina Single Cell Multiomics Introduction
11.10.4 Illimina Revenue in Single Cell Multiomics Business (2018-2023)
11.10.5 Illimina Recent Development
11.11 Miltenyi Biotec B.V. & CO.
11.11.1 Miltenyi Biotec B.V. & CO. Company Detail
11.11.2 Miltenyi Biotec B.V. & CO. Business Overview
11.11.3 Miltenyi Biotec B.V. & CO. Single Cell Multiomics Introduction
11.11.4 Miltenyi Biotec B.V. & CO. Revenue in Single Cell Multiomics Business (2018-2023)
11.11.5 Miltenyi Biotec B.V. & CO. Recent Development
11.12 Mission Bio
11.12.1 Mission Bio Company Detail
11.12.2 Mission Bio Business Overview
11.12.3 Mission Bio Single Cell Multiomics Introduction
11.12.4 Mission Bio Revenue in Single Cell Multiomics Business (2018-2023)
11.12.5 Mission Bio Recent Development
11.13 Nanostring Technologies
11.13.1 Nanostring Technologies Company Detail
11.13.2 Nanostring Technologies Business Overview
11.13.3 Nanostring Technologies Single Cell Multiomics Introduction
11.13.4 Nanostring Technologies Revenue in Single Cell Multiomics Business (2018-2023)
11.13.5 Nanostring Technologies Recent Development
11.14 Olink Holding AB (Olink Proteomics)
11.14.1 Olink Holding AB (Olink Proteomics) Company Detail
11.14.2 Olink Holding AB (Olink Proteomics) Business Overview
11.14.3 Olink Holding AB (Olink Proteomics) Single Cell Multiomics Introduction
11.14.4 Olink Holding AB (Olink Proteomics) Revenue in Single Cell Multiomics Business (2018-2023)
11.14.5 Olink Holding AB (Olink Proteomics) Recent Development
11.15 Parse Bioscience
11.15.1 Parse Bioscience Company Detail
11.15.2 Parse Bioscience Business Overview
11.15.3 Parse Bioscience Single Cell Multiomics Introduction
11.15.4 Parse Bioscience Revenue in Single Cell Multiomics Business (2018-2023)
11.15.5 Parse Bioscience Recent Development
11.16 Qiagen N.V.
11.16.1 Qiagen N.V. Company Detail
11.16.2 Qiagen N.V. Business Overview
11.16.3 Qiagen N.V. Single Cell Multiomics Introduction
11.16.4 Qiagen N.V. Revenue in Single Cell Multiomics Business (2018-2023)
11.16.5 Qiagen N.V. Recent Development
11.17 Takara Holdings Inc. Takara Bio Group
11.17.1 Takara Holdings Inc. Takara Bio Group Company Detail
11.17.2 Takara Holdings Inc. Takara Bio Group Business Overview
11.17.3 Takara Holdings Inc. Takara Bio Group Single Cell Multiomics Introduction
11.17.4 Takara Holdings Inc. Takara Bio Group Revenue in Single Cell Multiomics Business (2018-2023)
11.17.5 Takara Holdings Inc. Takara Bio Group Recent Development
11.18 Thermo Fisher Scientific
11.18.1 Thermo Fisher Scientific Company Detail
11.18.2 Thermo Fisher Scientific Business Overview
11.18.3 Thermo Fisher Scientific Single Cell Multiomics Introduction
11.18.4 Thermo Fisher Scientific Revenue in Single Cell Multiomics Business (2018-2023)
11.18.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
10x Genomics
Becton, Dickinson and Company
Berkeley Lights
BGI Genomics
Bio Rad Laboratories
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Epicypher
Fluidigm Corporation
Illimina
Miltenyi Biotec B.V. & CO.
Mission Bio
Nanostring Technologies
Olink Holding AB (Olink Proteomics)
Parse Bioscience
Qiagen N.V.
Takara Holdings Inc. Takara Bio Group
Thermo Fisher Scientific
听
听
*If Applicable.
